z-logo
open-access-imgOpen Access
Antimicrobial Activity of a Cationic Guanidine Compound against Two Pathogenic Oral Bacteria
Author(s) -
Erandi Escamilla García,
A. G. Alcázar-Pizaña,
Juan Carlos Segoviano-Ramírez,
Casiano del Angel-Mosqueda,
Ada Pricila López-Lozano,
Eloy CárdenasEstrada,
Myriam Angélica De la Garza-Ramos,
Carlos E. MedinaDe la Garza,
Marcela Márquez
Publication year - 2017
Publication title -
international journal of microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.696
H-Index - 40
eISSN - 1687-9198
pISSN - 1687-918X
DOI - 10.1155/2017/5924717
Subject(s) - guanidine , antimicrobial , cationic polymerization , pathogenic bacteria , microbiology and biotechnology , bacteria , medicine , chemistry , biology , organic chemistry , genetics
This study evaluated the potential antimicrobial properties of a polyguanidine (CatDex) on two oral bacteria. Chlorhexidine gluconate 1340  μ moL L −1 (CHX 0.12%) was used as control. Streptococcus mutans (S. mutans) and Porphyromonas gingivalis (P. gingivalis) were grown in BHI media. Bacterial sensitivity and antimicrobial activity were determined by the minimum inhibitory concentration (MIC) and Kirby-Bauer methods. To study side effects, that is, toxicity, dental pulp stem cells (DPSCs) were used. Fluorometric cytotoxicity and confocal microscopy assays were used in order to test cell viability. CatDex inhibited growth of S. mutans at all concentrations and growth of P. gingivalis at all concentrations except 25  μ moL L −1 . The MIC of CatDex was 50  μ moL L −1 for both S. mutans and P. gingivalis . The inhibition of bacteria exposed for 8 h at 50  μ moL L −1 of CatDex exhibited increased antimicrobial activity over time, with 91% inhibition in both bacteria. The antimicrobial activities of CatDex and CHX were similar when tested on two common bacteria. CatDex was significantly less toxic to DPSCs. CatDex toxicity depended on time and not on concentration. With regard to clinical relevance, CatDex may have potential as a novel antimicrobial agent. Further studies are in progress.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom